These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 11530045)

  • 1. Ring melanoma of the anterior chamber angle: a report of fourteen cases.
    Demirci H; Shields CL; Shields JA; Eagle RC; Honavar S
    Am J Ophthalmol; 2001 Sep; 132(3):336-42. PubMed ID: 11530045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ring melanoma of the ciliary body: report on twenty-three patients.
    Demirci H; Shields CL; Shields JA; Honavar SG; Eagle RC
    Retina; 2002 Dec; 22(6):698-706; quiz 852-3. PubMed ID: 12476094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse iris melanoma: a report of 25 cases.
    Demirci H; Shields CL; Shields JA; Eagle RC; Honavar SG
    Ophthalmology; 2002 Aug; 109(8):1553-60. PubMed ID: 12153810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ring melanoma of the anterior chamber angle as a mimicker of pigmentary glaucoma.
    Stadigh A; Puska P; Vesti E; Ristimäki A; Turunen JA; Kivelä TT
    Surv Ophthalmol; 2017; 62(5):670-676. PubMed ID: 28159633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.
    Kim EA; Salazar D; McCannel CA; Kamrava M; Demanes DJ; Lamb J; Caprioli J; McCannel TA
    J Glaucoma; 2020 Jan; 29(1):1-10. PubMed ID: 31688338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node metastases arising from uveal melanoma.
    Ardjomand N; Komericki P; Langmann G; Mattes D; Moray M; Scarpatetti M; El-Shabrawi Y
    Wien Klin Wochenschr; 2005 Jun; 117(11-12):433-5. PubMed ID: 16053201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.
    Detorakis ET; Engstrom RE; Wallace R; Straatsma BR
    Ophthalmology; 2005 Mar; 112(3):505-10. PubMed ID: 15745782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ring melanoma].
    Szuścik I; Romanowska-Dixon B; Jakubowska B; Orłowska-Heitzman J
    Klin Oczna; 2008; 110(10-12):375-9. PubMed ID: 19195170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uveal tumour resection.
    Char DH; Miller T; Crawford JB
    Br J Ophthalmol; 2001 Oct; 85(10):1213-9. PubMed ID: 11567967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications.
    Shields CL; Naseripour M; Shields JA; Freire J; Cater J
    Am J Ophthalmol; 2003 May; 135(5):648-56. PubMed ID: 12719072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse Anterior Retinoblastoma with Globe Salvage and Visual Preservation in 3 Consecutive Cases.
    Shields CL; Lally SE; Manjandavida FP; Leahey AM; Shields JA
    Ophthalmology; 2016 Feb; 123(2):378-384. PubMed ID: 26522706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant transformation of an iris melanocytoma. A case report.
    Cialdini AP; Sahel JA; Jalkh AE; Weiter JJ; Zakka K; Albert DM
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(4):348-54. PubMed ID: 2777104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciliary body melanoma with limited nodular extrascleral extension and diffuse iris-angle infiltration treated by whole anterior segment plaque radiotherapy.
    Gray ME; Corrêa ZM; Augsburger JJ; Barrett W
    Int Ophthalmol; 2007 Aug; 27(4):273-6. PubMed ID: 17468833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iris melanoma: risk factors for metastasis in 169 consecutive patients.
    Shields CL; Shields JA; Materin M; Gershenbaum E; Singh AD; Smith A
    Ophthalmology; 2001 Jan; 108(1):172-8. PubMed ID: 11150284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enucleation after plaque radiotherapy for posterior uveal melanoma. Histopathologic findings.
    Shields CL; Shields JA; Karlsson U; Menduke H; Brady LW
    Ophthalmology; 1990 Dec; 97(12):1665-70. PubMed ID: 2087297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma.
    Chaudhry IA; Liu M; Shamsi FA; Arat YO; Shetlar DJ; Boniuk M
    Retina; 2009 Jan; 29(1):73-9. PubMed ID: 18728617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma.
    Seregard S; Lundell G; Lax I; af Trampe E; Kock E
    Acta Ophthalmol Scand; 1997 Apr; 75(2):148-54. PubMed ID: 9197561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with elevated intraocular pressure in eyes with iris melanoma.
    Shields CL; Materin MA; Shields JA; Gershenbaum E; Singh AD; Smith A
    Br J Ophthalmol; 2001 Jun; 85(6):666-9. PubMed ID: 11371484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.